GIPL
Global Innovative Platforms Inc.0.1110
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
69.00KP/E (TTM)
-Basic EPS (TTM)
-46.28Dividend Yield
0%Recent Filings
10-Q
Q1 FY2026 results
Global Innovative Platforms notched first revenue of $30,000 in Q1 FY2026 ended December 31, 2025, from its VOCAM Plus tech under a deal with a global animal health firm—up from zero a year ago—while slashing operating loss to $49,429 from $120,467 (y/y). Expenses dropped sharply, R&D to $10,681 from $34,250 and G&A to $68,748 from $86,217, as setup costs eased. Cash climbed to $49,004 on $18,500 stock sales, despite $12,676 operating outflow; no debt, but $55,500 deferred revenue awaits delivery. Shares outstanding rose to 45.98M from 44.48M q/q. Losses narrow fast.
10-K
FY2025 results
Global Innovative Platforms posted FY2025 net loss of $718k, up from $136k in FY2024, driven by R&D ramp to $383k from $23k as algorithm development advanced with promising heartworm breathprint identification from small dog studies. No revenue yet, but $85k billed post-year-end; cash dwindled to $18k after $754k stock raises funded $175k product investments and $561k ops burn. License payments hit $142k. Thinly traded. Dependence on single vendor risks delays.
8-K
Early heartworm breath detection
Global Innovative Platforms posted an updated investor presentation on November 24, 2025, alongside early AI analysis of VOCAM Plus breath data from dogs. Preliminary results reveal distinct VOC profiles for heartworm-free (6/6 predicted), early-stage (17/18), and mature infections (10/10), spotting patterns invisible to antigen tests. Findings encourage early detection push. More testing ahead.
8-K
VOCAM deal, auditor switch
Global Innovative Platforms inked a deal on November 2, 2025, with a global animal health firm to supply VOCAM Plus diagnostic units for canine heartworm detection evaluation. Days later, on November 3, it dismissed auditor MSMR—clean break, no disagreements—and tapped CNGSN as replacement. Smooth audit switch. This partnership validates breathomics tech amid accounting housekeeping.
8-K
Updated investor presentation posted
CEP
Cantor Equity Partners, Inc.
14.27-0.16
CEPO
Cantor Equity Partners I, Inc.
10.58+0.06
COPL
Copley Acquisition Corp
10.21+0.00
FWFW
Flywheel Advanced Technology In
0.07+0.00
GLLI
Globalink Investment Inc.
3.00-8.50
GPAT
GP-Act III Acquisition Corp.
10.66+0.00
GPLB
GREEN PLANET BIOENGINEERING CO
0.01+0.00
GRAF
Graf Global Corp.
10.71-0.14
GTERA
Globa Terra Acquisition Corpora
10.08-0.01
SIPN
SIPP International Industries,
0.00+0.00